Evozyne
PrivateLast Round
Series B
Sep 27, 2023
Total Funding Raised
$149.18M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Evozyne operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a Series B round in September 2023.
Evozyne is a biotechnology company that operates a data-driven molecular engineering platform to develop innovative proteins with enhanced functionalities tailored to meet specific health challenges.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Infrastructure
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Evozyne Comparables
Compare Evozyne with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nabla | 88% | |
| AI Proteins | 86% | |
| Profluent Bio | 85% |
For institutional investors. Book with your work email.
Evozyne Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 27, 2023 | ||||
| Series A | Apr 21, 2021 | ||||
| Seed | Apr 27, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Evozyne Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Fidelity Management & Research Company | Series A, Series B |
| OrbiMed | Series B |
| Paragon Biosciences | Seed, Series B, Series A |
| NVentures | Series B |
| Valor Equity Partners | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 87% MoM, from 2.7K to 5K.
- Sep 27, 2023
$81M round led by Fidelity Management & Research Company and OrbiMed.
For institutional investors. Book with your work email.
Evozyne Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Evozyne's valuation, stock price, and market status.
Is Evozyne a public or private company?
Evozyne is a private company.
What is the current stock price of Evozyne?
Evozyne is a private company, so its shares have no public market price. Caplight tracks Evozyne's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Evozyne worth (valuation)?
Valuation information for Evozyne is not publicly available.
Can I buy Evozyne stock?
Evozyne shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Evozyne's last funding round?
Evozyne's most recent funding round was Series B on September 27, 2023.
Who are the main investors in Evozyne?
Key investors in Evozyne include Fidelity Management & Research Company, OrbiMed.
Will Evozyne IPO soon?
No public IPO plans have been announced for Evozyne.
How can I track Evozyne secondary market activity?
Caplight tracks bids, offers, and trades in Evozyne's shares on secondary markets.